The estimated Net Worth of Sammy Karam is at least $4.2 Million dollars as of 29 December 2022. Mr. Karam owns over 4,200 units of Abbott Laboratories stock worth over $3,085,469 and over the last 6 years he sold ABT stock worth over $1,114,750. In addition, he makes $0 as Senior Vice President - Established Pharmaceuticals and Emerging Markets at Abbott Laboratories.
Sammy has made over 5 trades of the Abbott Laboratories stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 4,200 units of ABT stock worth $456,750 on 29 December 2022.
The largest trade he's ever made was exercising 8,600 units of Abbott Laboratories stock on 27 April 2021 worth over $652,740. On average, Sammy trades about 1,971 units every 36 days since 2019. As of 29 December 2022 he still owns at least 26,462 units of Abbott Laboratories stock.
You can see the complete history of Mr. Karam stock trades at the bottom of the page.
Sammy Karam serves as Senior Vice President - Established Pharmaceuticals, Emerging Markets of the Company. He serve as Divisional Vice President, Global Marketing Commercial Execution, Established Pharmaceuticals from 2014-2019.
Sammy Karam is 58, he's been the Senior Vice President - Established Pharmaceuticals and Emerging Markets of Abbott Laboratories since 2019. There are 21 older and 17 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Sammy's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez, and Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: